EUFOREA consensus on biologics for CRSwNP with or without asthma

Novel therapies such as type 2 targeting biologics are emerging treatment options for patients with chronic inflammatory respiratory diseases, fulfilling the needs of severely uncontrolled patients. The majority of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and over half of pati...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Allergy (Copenhagen) Ročník 74; číslo 12; s. 2312 - 2319
Hlavní autori:	Fokkens, Wytske J., Lund, Valerie, Bachert, Claus, Mullol, Joaquim, Bjermer, Leif, Bousquet, Jean, Canonica, Giorgio W., Deneyer, Lauren, Desrosiers, Martin, Diamant, Zuzana, Han, Joseph, Heffler, Enrico, Hopkins, Claire, Jankowski, Roger, Joos, Guy, Knill, Andrew, Lee, Jivianne, Lee, Stella E., Mariën, Gert, Pugin, Benoit, Senior, Brent, Seys, Sven F., Hellings, Peter W.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Denmark Blackwell Publishing Ltd 01.12.2019 Wiley John Wiley and Sons Inc
Predmet:	Allergies Allergology Asthma Asthma - complications Biological products Biological Products - administration & dosage Biological Products - adverse effects Biological Products - therapeutic use biologics Chronic Disease chronic rhinosinusitis Clinical Decision-Making Clinical Medicine Comorbidity Disease Management Health Services Needs and Demand Human health and pathology Humans Immunoglobulin E Immunology Immunotherapy Interleukin 5 Klinisk medicin Life Sciences Lungmedicin och allergi Medical and Health Sciences Medicin och hälsovetenskap Mucosa nasal polyps Nasal Polyps - complications Polyps Pulmonology and respiratory tract Respiratory diseases Respiratory Medicine and Allergy Respiratory tract diseases Review Reviews Rhinitis Rhinitis - complications Rhinitis - drug therapy Rhinosinusitis Sinusitis Sinusitis - complications Sinusitis - drug therapy Treatment Outcome type 2 inflammation chronic rhinosinusitis nasal polyps asthma biologics type 2 inflammation
ISSN:	0105-4538, 1398-9995, 1398-9995
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!